used more and more in the treatment ot rheumatoid arthritis. Its potential role has been recognized by a committee of the American Rheumatism Association which is conducting a well-controlled multiclinic study of cyclophosphamide in this disease. The immunosuppressive drugs that have been used in the treatment of rheumatoid arthritis are nitrogen mustard (1-3), aza-thioprine (4-9), 6-mercaptopurine (9-11), chlorambucil (12-14), cyclophosphamide (15), and methotrexate (16). Recently, Mason and his colleagues (4) of the London Hospital published a pre-liminary communication on a double-blin
The development of personalized medicine to improve the outcome of patients with chronic inflammator...
Rheumatoid arthritis (RA) is among the mostimportant chronic diseases that can causejoint destructio...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
The use of immunosuppressive drugs in rheumatology is fairly recent, starting just after the Second ...
Immunosuppressive agents serve a major role in the management of once-fatal conditions such as the s...
OUR steadily increasing knowledge of mechanisms leading to tissue destruction in autoimmune rheumati...
Setting the research agenda for future clinical trials on the use of biologics in rheumatology Real-...
Aims: With the arrival of conventional synthetic (csDMARDs), biological (bDMARDS) and then targeted ...
IN an era of exploding biotechnology, which has had a profound impact on the treatment of other diso...
Glucocorticoids, since their spectacular introduc-tion into clinical medicine in 1948 (1), remain a ...
The 1997 literature included important informa-tion on new treatment approaches to rheuma-toid arthr...
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease leading to synovial hyperplasia a...
In recent years, the long term prognosis of patients with rheumatic disease has dramatically improve...
The treatment of rheumatoid arthritis traditionally includes symptomatic drugs, showing a prompt act...
Inflammation is the central and essential component of rheumatoid arthritis, and control of inflamma...
The development of personalized medicine to improve the outcome of patients with chronic inflammator...
Rheumatoid arthritis (RA) is among the mostimportant chronic diseases that can causejoint destructio...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
The use of immunosuppressive drugs in rheumatology is fairly recent, starting just after the Second ...
Immunosuppressive agents serve a major role in the management of once-fatal conditions such as the s...
OUR steadily increasing knowledge of mechanisms leading to tissue destruction in autoimmune rheumati...
Setting the research agenda for future clinical trials on the use of biologics in rheumatology Real-...
Aims: With the arrival of conventional synthetic (csDMARDs), biological (bDMARDS) and then targeted ...
IN an era of exploding biotechnology, which has had a profound impact on the treatment of other diso...
Glucocorticoids, since their spectacular introduc-tion into clinical medicine in 1948 (1), remain a ...
The 1997 literature included important informa-tion on new treatment approaches to rheuma-toid arthr...
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease leading to synovial hyperplasia a...
In recent years, the long term prognosis of patients with rheumatic disease has dramatically improve...
The treatment of rheumatoid arthritis traditionally includes symptomatic drugs, showing a prompt act...
Inflammation is the central and essential component of rheumatoid arthritis, and control of inflamma...
The development of personalized medicine to improve the outcome of patients with chronic inflammator...
Rheumatoid arthritis (RA) is among the mostimportant chronic diseases that can causejoint destructio...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...